| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |